Abstract
A primary objective of experimental teratology is to determine potential adverse effects of chemicals and other environmental agents on development prior to widespread human exposure. Ethical considerations prohibit the testing of compounds for teratogenicity in the human population. This constraint forces us to make extrapolations of potential human risk from data obtained in laboratory animal species. Interspecies differences in teratologic sensitivity make the selection of an appropriate animal model a particularly challenging problem. The use of nonhuman primates has been advocated on the basis of their phylogenetic relatedness to humans, as reflected in anatomical, reproductive, and embryological similarities. One objective of this chapter is to examine results of developmental toxicity studies in nonhuman primates and determine how faithfully they match known effects in humans. Retrospective analyses like these are useful in validating animal models, but in order to enhance our predictive capability we need a better understanding of the nature and extent of interspecies variations in developmental toxicity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andersen, A. C., Nelson, V. G., and Simpson, M. E. 1972. Fractionated X-radiation damage to developing monkey ovaries. J. Med. Primatol. 1:318–325.
Andersen, A. C., Hendrickx, A. G., and Momeni, M. H. 1977. Fractionated X-radiation damage to developing ovaries in the bonnet monkey (Macaca radiata) Radiat. Res. 71:398–405.
Arora, K. L., Cohen, B. J., and Beaudoin, A. R. 1979. Fetal and placental responses to artificially induced hyperthermia in rats. Teratology 19:251–260.
Ashby, R., Davis, L., Dewhurst, B. B., Espinal, R., Penn, R. N., and Upshall, D. G. 1976. Aspects of the teratology of cyclophosphamide (NSC-26271). Cancer Treat. Rep. 60:477–482.
Baker, T. G. 1969. The sensitivity of rat, monkey and human oocyte to X-radiation in organ culture, in: Radiation Biology of the Fetal and Juvenile Mammal. U. S. Atomic Energy Commission, Conf-690501, p. 955.
Baker, T. G. 1970. Comparative aspects of the effects of radiation during oogenesis. Mutat. Res. 11:9–22.
Baker, T. G., and Beaumont, H. M. 1967. Radiosensitivity of oogonia and oocytes in the foetal and neonatal monkey. Nature 214:981–983.
Baker, T. G., and Neal, P. 1969. The effects of X-irradiation on mammalian oocytes in organ culture. Biophysik 6:39.
Barrow, M. V., Steffek, A. J., and King, C. T. G. 1969. Thalidomide syndrome in rhesus monkeys (Macaca mulatta) Folia Primatol. 10:195–203.
Beaumont, H. M. 1962. The radiosensitivity of germ-cells at various stages of ovarian development. Int. J. Radiat. Biol. 4:581–590.
Beaumont, H. M. 1965. The short term effects of acute X-irradiation on oogonia and oocytes. Proc. R. Soc. B. 161:550–570.
Berry, C. L. 1971. Transient inhibition of DNA synthesis by methotrexate in the rat embryo and fetus. J. Embryol. Exp. Morphol. 26:469–474.
Bignami, G., Bovet, D., Bovet-Nitti, F., and Rosnati, V. 1962. Drugs and congenital abnormalities. Lancet 2:1333–1334.
Brent, R. L. 1971. Irradiation in pregnancy, in: Gynecology and Obstretics, Volume 2, J. J. Lovinsky, ed. Harper and Row, Harperstown, pp. 1–30.
Brent, R. L. 1977. Radiation and other physical agents, in: Handbook of Teratology, Volume 1, J. G. Wilson and F. C. Fraser, eds. Plenum, New York, pp. 153–223.
Brüggemann, S., and Grauwiler, J. 1975. The possibilities of using Macaca arctoides in teratological experiments. Lab. Anirn. Handb. 6:339–345.
Burner, J. A., and Witschi, E. 1946. Testosterone-induced modifications of sex development in female hamsters. Am. J. Anat. 79:293–320.
Butler, H. 1977. The effect of thalidomide on a prosimian: the greater galago (Galago crassicaudatus) J. Med. Primatol. 6:319–324.
Calabresi, P., and Parks, R. E., Jr. 1975. Alkylating agents, antimetabolites, hormones and other antiproliferative agents, in: The Pharmacological Basis of Therapeutics, 5th ed., L. S. Goodman and A. Gilman, eds. Macmillan, New York, pp. 1254–1307.
Chappel, C. I., Revesz, C., and Gaudry, R. 1960. Biological studies on new orally active 6,17-halogenated progesterones. Acta Endocrinal. Suppl. 51:915.
Chaube, S., and Murphy, M. L. 1966. The effects of hydroxyurea and related compounds on the rat fetus. Cancer Res. 26:1448–1457.
Chaube, S., King, G., and Murphy, M. L. 1967. Teratogenic effects of cyclophosphamide (NSC-26271) in the rat. Cancer Chemother. Rep. 51:363–376.
Christie, G. A. 1962. Thalidomide and congenital abnormalities. Lancet 2:249.
Coates, A. 1970. Cyclophosphamide in pregnancy. Aust. N. Z. J. Obstet. Gynecol. 10:33.
Courtney, K. D. 1968. Anon. FAO/WHO Report, cited in: U. S. Environmental Protection Agency Report No. 540/1–75–012. Office of Pesticide Programs. Substitute Chemical Program: Initial Scientific and Minieconomic Review of Captan. April 1975.
Curtis, E. M., and Grant, R. P. 1964. Masculinization of female pups by progesterone. J. Am. Med. Assoc. 144:395–398.
Dekaban, A. S. 1968. Abnormalities in children exposed to X-radiation during various stages of gestation: tentative timetable of radiation injury to the human fetus, part 1. J. Nucl. Med. 9 471–477
Dekker, A., and Mehrizi, A., 1964. The use of thalidomide as a teratogenic agent in rabbits. Bull. Johns Hopkins Hosp. 115:223–230.
Delahunt, C. S., and Lassen, C. B. 1964. Thalidomide syndrome in monkeys. Science 146:1300–1301.
Diamond, I., Anderson, M. M., and McCreadie, S. R. 1960. Transplacental transmission of busulfan (Myleran) in a mother with leukemia. Pediatrics 25:85–90.
DiPaolo, J. 1963. Congenital malformation in strain A mice. Its experimental production by thalidomide. J. Am. Med. Assoc. 183:139–141.
Dwornik, J. J., and Moore, K. L. 1965. Skeletal malformations in the Holtzman rat embryo following administration of thalidomide. J. Embryol. Exp. Morphol. 13:181–193.
Edwards, M. J. 1967. Congenital defects in guinea pigs following induced hyperthermia during gestation. Arch. Pathol. 84:42–48.
Edwards, M. J. 1969. Congenital defects in guinea pigs: fetal resorptions, abortions, and malformation following induced hyperthermia. Teratology 2:313–328.
Edwards, M. J. 1974. The effects of hyperthermia on pregnancy and prenatal development. Exp. Embryol. Teratol. 1:90–133.
Erickson, B. H. 1966. Development and radio-response of the prenatal bovine ovary. J. Reprod. Fertil. 11:97–105.
Fabro, S., Smith, R. L., and Williams, R. T. 1966. Embryotoxic activity of some pesticides and drugs related to phthalimide. Food Cosmet. Toxicol. 3:587–590.
Felisati, D. 1962. Thalidomide and congenital abnormalities. Lancet 2:724–725.
Ferm, V. H. 1965. Teratogenic activity of hydroxyurea. Lancet 1:1138–1139.
Fraser, F. C., and Skelton, J. 1978. Possible teratogenicity of maternal fever. Lancet 2:634.
Fratta, I. D., Sigg, E. B., and Maiorana, K. 1965. Teratogenic effects of thalidomide in rabbits, rats, hamsters, and mice. Toxicol. Appi. Pharmacol. 7:268–286.
Fritz, H., and Hess, R. 1971. Effects of cyclophosphamide on embryonic development in the rabbit. Agents Actions 2:83–86.
Gebhardt, D. O. E. 1970. The embryolethal and teratogenic effects of cyclophosphamide on mouse embryos. Teratology 3:273–278.
Gerlinger, P. 1964. Action du cyclophosphamide injecté à la mère sur la réalisation de la forme du corps des embryons de lapin. C. R. Soc. Biol. 158:2154–2157.
Gerlinger, P., and Clavert, J. 1965. Anomalies observées chez les lapins issus de mères traitées en cyclophosphosphamide. C. R. Soc. Biol. 159:1462–1466.
Giacone, J., and Schmidt, L. H. 1970. Internal malformations produced by thalidomide and related compounds in rhesus monkeys. Anat. Rec. 166:306 (abstract).
Gibson, J. E., and Becker, B. A. 1968. The teratogenicity of cyclophosphamide in mice. Cancer Res. 28:475–480.
Giroud, A., Tuchmann-Duplessis, H., and Mercier-Parot, L. 1962a. Influence de la thalidomide sur le développement foetal. Bull. Acad. Nat. Med. 146:343–345.
Giroud, A., Tuchmann-Duplessis, H., and Mercier-Parot, L. 1962b. Observations sur les répercussions tératogènes de la thalidomide chez la souris et la lapin. C. R. Soc. Biol. 156:765–768.
Giroud, A., Tuchmann-Duplessis, H., and Mercier-Parot, L. 1962c. Production de malformations congénitale chez la souris après administration de faibles doses de thalidomide. C. R. Acad. Sci. 225:1646–1648.
Giroud, A., Tuchmann-Duplessis, H., and Mercier-Parot, L. 1962d. Thalidomide and congenital abnormalities. Lancet 2:298–299.
Globus, M. and Gibson, M. A. 1968. A histological and histochemical study on the development of the sternum in thalidomide-treated rats. Teratology 1:235–256.
Goetsch, C. 1962. An evaluation of aminopterin as an abortifacient. Am. J. Obstet. Gynecol. 83:1474.
Greenburg, L. H., and Tanaka, K. R. 1964. Congenital anomalies probably induced by cyclophosphamide. J. Am. Med. Assoc. 188:423–426.
Greene, R. M., and Kochhar, D. M. 1975. Some aspects of corticosteroid-induced cleft palate: a review. Teratology 11:47–56.
Griem, M. L., Meier, P., and Dobben, G. D. 1967. Analysis of the morbidity and mortality of children irradiated in fetal life. Radiology 88:347.
Hackenberger, I., and Kreybig, T. V. 1965. Vergleichende teratologische untersuchungen bei der maus und bei der ratte. Arzneim. Forsch. 15:1456–1460.
Hammer-Jacobsen, E. 1961. Congenital malformations induced by radiation: a brief survey of the literature. Strahlentherapie 116:152.
Hay, M. F. 1964. Effects of thalidomide on pregnancy in the rabbit. J. Reprod. Fertil. 8:59–76.
Hendrickx, A. G. 1971. Teratogenicity of thalidomide in the baboon (Papio cynocephalus), bonnet monkey (Macaca radiata), and cynomolgus monkey (Macaca irus), in: Proceedings of the 3rd International Congress of Primatology, Zurich, 1970, Volume 2, J. Biegert and W. Leutenegger, eds. Karger, Basel, pp. 230–237.
Hendrickx, A. G. 1972. A comparison of temporal factors in the embryological development of man, old world monkeys, and galagos, and craniofacial malformations induced by thalidomide and triamcinolone, in: Medical Primatology , PartIII. Karger, Basel, pp. 259–269.
Hendrickx, A. G. 1973. The sensitive period and malformation syndrome produced by thalidomide in the crab-eating monkey (Macaca fascicularis) J. Med. Primatol. 2:267–276.
Hendrickx, A. G., and Binkerd, P. E. 1980. Fetal deaths in nonhuman primates, in: Human Embryonic and Fetal Death. I H. Porter and E. B. Hook, eds. Academic, New York, pp. 45–69.
Hendrickx, A. G., and Newman, L. 1973. Appendicular skeletal and visceral malformations induced by thalidomide in bonnet monkeys. Teratology 7:151–160.
Hendrickx, A. G., and Sawyer, R. H. 1978. Developmental staging and thalidomide teratogenicity in the Green monkey (Cercopithecus aethiops) Teratology 18:393–404.
Hendrickx, A. G., Axelrod, L. R., and Clayborn, L. D. 1966. Thalidomide syndrome in baboons. Nature 210:958–959.
Hendrickx, A. G., Sawyer, R. H., Terrell, T. G., Osburn, B. I., Henrickson, R. V., and Steffek, A. J. 1975. Teratogenic effects of triamcinolone on the skeletal and lymphoid system in nonhuman primates. Fed. Proc. 34:1661–1665.
Hendrickx, A. G., Stone, G. W., Henrickson, R. V., and Matayoshi, D. 1979. Teratogenic effects of hyperthermia in the bonnet monkey (Macaca radiata) Teratology 19:177–182.
Hendrickx, A. G., Pellegrini, M., Tarara, R., Parker, R., Silverman, S., and Steffek, A. J. 1980. Craniofacial and central nervous system malformations induced by triamcinolone acetonide in nonhuman primates. I. General teratogenicity. Teratology 22:103–114.
Ingalls, T. H., Curley, F. J., and Zappasodi, P. 1964. Thalidomide embryopathy in hybrid rabbits. N. Engl. J. Med. 271:441–444.
Jacobson, B. D. 1962. Hazards of norethindrone therapy during pregnancy. Am. J. Obstet. Gynecol. 84:962–968.
Johnstone, E. R., and Franklin, R. R. 1964. Assay of progestins for foetal virilizing properties using the mouse. Obstet. Gynecol. 23:359–362.
Jordan, R. L., Wilson, J. G., and Schumacher, H. J. 1977. Embyotoxicity of the folate antagonist methotoxate in rats and rabbits. Teratology 15:73–80.
Kennedy, G., Faucher, O. E., and Calandra, J. C. 1968. An investigation of the teratogenic potential of captan, folpet and difolatan. Toxicol. Appl. Pharmacol. 13:420–430.
Khera, K. S. 1979. Teratogenicity study on hydroxyurea and diphenylhydantoin in cats. Teratology 20:447–452.
King, C. T. G., and Kendrick, F. J. 1962. Teratogenic effects of thalidomide in the Sprague-Dawley rat. Lancet 2:1116.
Klein-Obbink, H. J., and Dalderup, L. M. 1964. Effects of thalidomide on the skeleton of the rat fetus. Experientia 20:283–284.
Kohler, F., and Koch, H. 1974. Teratologische Untersuchung der Thalidomidahnlichen Verbindungen K-2004 und K-2604 an Maus und Ratte. Arzneim. Forsc. 24:1616–1618.
Kraay, R. J., and Brennan, D. M. 1963. Evaluation of chlormadinone acetate and other progestogens for foetal masculinisation in rats. Acta Endocrinol. 43:412–418.
Lechat, P., Deleau, D., Boime, A., and Bunot, O. 1964. Résultats négatifs d’une recherche des effets tératogènes éventuels du N-méthylphtalimide. Therapie 19:1393–1403.
Leone, V. G. 1977. Comparative aspects of developmental stages in mammals used for teratogenic tests, in: Methods in Prenatal Toxicology, Evaluation of Embryotoxic Effects in Experimental Animals, D. Neubert, H.-J. Merker, and T. E. Kwashigroch, eds. Thieme, Stuttgart, pp. 14–24.
Lerner, L. J., De Phillipo, M., Yiacas, E., Brennan, D., and Borman, A. 1962. Comparison of the acetophenone derivatives of 16α,17β-dihydroxyprogesterone with other progestational steroids for masculinization of the rat foetus. Endocrinology 71:448–451.
Marois, M. 1960. Action of three progestational agents active per os upon the genital tract of the rat foetus (in French). Bull. Acad. Nat. Med. 144:518–526.
McClure, H. M., Wilk, A. L., Horigan, E. A., and Pratt, R. M. 1979. Induction of craniofacial malformations in rhesus monkeys (Macaca mulatta) with cyclophosphamide. Cleft Palate J. 16:248–256.
McColl, J. D., Globus, M., and Robinson, S. 1963. Drug induced skeletal malformations in the rat. Experientia 19:183–184.
McColl, J. D., Globus, M., and Robinson, S. 1965. Effect of some therapeutic agents on the developing rat fetus. Toxicol. Appl. Pharmacol. 7:409–417.
McLaughlin, J., Jr., Reynaldo, E. F., Lamar, J. K., and Marliac, J. P. 1969. Teratology studies in rabbits with captan, folpet, and thalidomide. Toxicol. Appl. Pharmacol. 14:641.
Methah, D., Reznick, G., and Schlegel, D. 1976. Experimentally induced cleft palates and prophylactic studies in Swiss mice. J. Oral Pathol. 5:209–216.
Miller, P., Smith, D. W., and Shepard, T. H. 1978. Maternal hyperthermia as a possible cause of anencephaly. Lancet 1:519–521.
Milunsky, A., Graef, J. W., and Gaynor, M. F. 1968. Methotrexate-induced congenital malformations. J. Pediatr. 72:790–795.
Moore, K. L., Dwornik, J. J., and Dalton, R. D. 1964. Congenital defects produced in the rat by thalidomide. Anat. Rec. 148:313–314.
Moreau, M.-G. 1964. Action des hormones sexuelles sur la différenciation sexuelle de la distance ano-génitale et du tubercule génital du foetus de rat. Arch. Anat. Microsc. 53:367–386.
Murad, J. E., and Alvarenga, R. J. 1964. Amélie et micromélie provoquées par le thalidomide chez le foetus de souris. Thérapie 19:1405–1409.
Murphy, D. P. 1929. Outcome of 625 pregnancies in women subjected to pelvic radium or roentgen irradiation. Am. J. Obstet. Gynecol. 18:179.
Murphy, M. L. 1962. Teratogenic effects in rats of growth inhibiting chemicals, including studies on thalidomide. Clin. Proc. Child. Hosp. Wash. 18:307–322.
Neumann, F., and Kramer, M. 1964. Antagonism of androgenic and anti-androgenic agents in their action on the rat foetus. Endocrinology 75:428–433.
Newman, L. M., and Hendrickx, A. G. 1981. Fetal malformations induced by maternal ingestion of thalidomide in the bonnet monkey (Macaca radiata) Teratology 23:351–364.
Nicholson, H. O. 1968. Cytotoxic drugs in pregnancy. J. Obstet. Gynecol. Br. Comm. 75:307–312.
Nishimura, H., and Tanimura, T. 1976. Clinical Aspects of the Teratogenicity of Drugs. American Elsevier, New York.
Ozzello, L., and Rugh, R. 1965. Acute pathologic alterations in X-irradiated primate fetuses. Am. J. Roentgenol. 93:209–221.
Parker, R. M. 1980. Triamcinolone acetonide teratogenicity in nonhuman primates: general teratogenicity in the baboon and the pathogenesis of craniofacial defects in the rhesus monkey. Ph. D. Dissertation, University of California, Davis.
Pearn, J. H., and Vickers, T. 1966. The rabbit thalidomide embryopathy. Br. J. Exp. Pathol. 47:186–192.
Peters, H., and Levy, E. 1963. Effect of irradiation in infancy on the fertility of female mice. Radiat. Res. 18:421–428.
Peters, H., and Levy, E. 1964. Effect of irradiation in infancy on the mouse ovary. J. Reprod. Fertil. 7:37–45.
Pliess, G. 1962. Thalidomide and congenital abnormalities. Lancet 1:1128–1129.
Plummer, G. 1952. Anomalies occurring in children exposed in utero to atomic bombs in Hiroshima. Pediatrics 10:687–693.
Poswillo, D. E., Hamilton, W. J., and Sopher, D. 1972. The marmoset as an animal model for teratological research. Nature 239:460–462.
Poswillo, D., Nunnerly, H., Sopher, D., and Keith, J. 1974. Hyperthermia as a teratogenic agent. Ann. R. Coll. Surg. Engl. 55:171–174.
Powell, H. R., and Ekert, H. 1971. Methotrexate-induced congenital malformations. Med. J. Aust. 2:1076–1077.
Raynaud, A. 1937. Intersexualité provoquée chez la souris femelle par injection d’hormone mâle á la mère en gestation. C. R. Soc. Biol. 126:866–868.
Revesz, C., Chappel, C. I., and Gaudry, R. 1960. Masculinization of female fetuses in the rat by progestational compounds. Endocrinology 66:140–144.
Robens, J. F. 1970. Teratogenic activity of several phthalimide derivatives in the golden hamster. Toxicol. Appl. Pharmacol. 16:24–34.
Roll, R., and Bär, F. 1969. Untersuchungen über die teratogene Wirking von Hydroxyharnstoff während der frühen und embryonalen Entwicklung der Maus. Arch. Toxikol. 25:150–168.
Rowland, J. M. 1981. Metabolism and distribution of triamcinolone acetonide and cortisol in the rat embryomaternal unit: relationship to teratogenicity. Ph. D. Dissertation, University of California, Davis.
Rowland, J. M., and Hendrickx, A. G. 1979. Triamcinolone acetonide teratogenesis in Sprague Dawley rats. Teratology 19:44A (abstract).
Rugh, R., and Wohlfromm, M. 1966. Resistance of the prenatal female mouse to X-ray sterilization. Fertil. Steril. 17:396–410.
Rugh, R., Duhamel, L., Skaredoff, L., and Somogyi, C. 1966a. Gross sequelae of fetal X-irradiation of the monkey (Macaca mulatta). I. Effect on body and organ weights at 23 months. Atompraxis 12:468–473.
Rugh, R., Duhamel, L., Skaredoff, L., and Somogyi, C. 1966-b. Gross sequelae of fetal X-irradiation of the monkey (Macaca mulatta). II. Functional effects revealed by EEG, ERG, and EKG recordings. Atompraxis 12:519–524.
Salomon, D. S., and Pratt, R. M. 1979. Involvement of glucocorticoids in the development of the secondary palate. Differentiation 13:141–154.
Sawyer, R. E., Hendrickx, A. G., Osburn, B., Terrell, T., and Anderson, J. 1977. Abnormal morphology of the fetal monkey (Macaca mulatta) thymus exposed to a corticosteroid. J. Med. Primatol. 6:145–150.
Schardein, J. L. 1980. Congenital abnormalities and hormones during pregnancy: a clinical review. Teratology 22:251–270.
Scholer, H. F. L., and de Wachter, A. M. 1961. Evaluation of androgenic properties of progestational compounds in the rat by the female foetal masculinisation test. Acta Endocrinol. 38:128–136.
Schumacher, H., Blake, D. A., Gurian, J. M., and Gillette, J. R. 1968a. A comparison of the teratogenic activity of thalidomide in rabbits and rats. J. Pharmacol. Exp. Ther. 160:189–200.
Schumacher, H., Blake, D., and Gillette, J. 1968b. Disposition of thalidomide in rabbits and rats. J. Pharmacol. Exp. Ther. 160:201–211.
Schumacher, H., Wilson, J. G., Terapane, J., and Rosedale, S. 1970. Thalidomide: disposition in rhesus monkey and studies of its hydrolysis in tissues of this and other species. J. Pharmacol. Exp. Ther. 173:265–269.
Scott, W. J., Fradkin, R., and Wilson, J. G. 1977. Non-confirmation of thalidomide induced teratogenesis in rats and mice. Teratology 16:333–335.
Seller, M. J. 1962. Thalidomide and congenital abnormalities. Lancet 2:249.
Shah, R. M., and Kilistoff, H. 1976. Cleft palate induction in hamster fetuses by glucocorticoid hormones and their synthetic analogues. J. Embryol. Exp. Morphol. 36:101–108.
Siddall, R. A. 1978. Use of marmosets (Callithrix jacchus) in teratological and toxicological research. Primates Med. 10:215–224.
Singh, S. 1971. The teratogenicity of cyclophosphamide (Endoxan-Asta) in rats. Indian J. Med. Res. 59:1128–1135.
Skalko, R. G., and Gold, M. P. 1974. Teratogenicity of methotrexate in mice. Teratology 9:159–164.
Smith, D. W., Clarren, S. K., and Sedgwick Harvey, M. A. 1978. Hyperthermia as a possible teratogenic agent. J. Pediatr. 92:878–883.
Somers, G. F. 1962. Thalidomide and congenital abnormalities. Lancet 1:912–913.
Somers, G. F. 1963. The foetal toxicity of thalidomide. Proc. Eur. Soc. Study Drug Toxicol. 1:49–58.
Staples, R., and Holtkamp, D. E. 1963. Effects of parental thalidomide treatment on gestation and fetal development. Exp. Mol. Pathol. Suppl. 2:81–106.
Stutzman, L., and Sokal, J. E. 1968. Use of anticancer drugs during pregnancy. Clin. Obstet. Gynecol. 11:416–427.
Suchowsky, G., and Junkmann, K. 1960. On the problem of the virilization of the fetus through treatment of the mother with gestagens. (in German). Geburtshilfe Frauenheilkd. 20:1019–1023.
Suchowsky, G. K., and Junkmann, K. 1961. A study of the virilizing effect of progestogens on the female rat foetus. Endocrinology 68:341–349.
Suchowsky, G. K., Turolla, E., and Arcari, G. 1967. Studies of the so-called virilizing effects of steroids in female rat foetuses. Endocrinology 80:255–262.
Tanimura, T. 1972. Effects on macaque embryos of drugs reported or suspected to be teratogenic to humans. Acta Endocrinol. 166 (Suppl.):293–308.
Theisen, C. T., Fradkin, R., and Wilson, J. G. 1973. Teratogenicity of hydroxyurea in rhesus monkeys. Teratology 7:29A (abstract).
Theisen, C. T., Bodin, J. D., Svoboda, J. A., and Pettinelli, M. W. 1979. Unusual muscle abnormalities associated with thalidomide treatment in a rhesus monkey: a case report. Teratology 19:313–319.
Thiersch, J. B. 1952. Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino P. G. A.) administered by the oral route. Am. J. Obstet. Gynecol. 63:1298–1304.
Thiersch, J. B. 1956. The control of reproduction in rats with the aid of antimetabolites. Early experiences with antimetabolites as abortifacient agents in man. Acta. Endocrinol. 28 (Suppl.):37–45.
Toledo, T. M., Harper, R. C., and Moser, R. H. 1971. Fetal effects during cyclophosphamide and irradiation therapy. Ann. Int. Med. 74:87–91.
Tshibangu, K., Leroy, F., and Doumont-Meyris, M. 1975. Effects of amethopterin (methotrexate) on the evolution of pregnancy in rats. Toxicology 4:65–73.
Turner, C. D. 1939. The modification of sexual differentiation in genetic female mice by the prenatal administration of testosterone propionate. J. Morphol. 65:353–381.
Ujhazy, E., Preinerová, M., and Jozefik, M. 1979. Effect of cyclophosphamide on the prenatal development of the Swiss strain mice. Neoplasma 26:529–537.
Umpierre, C. C., and Dukelow, R. 1977. Environmental heat stress effects in the hamster. Teratology 16:155–158.
van Wagenen, G., and Hamilton, J. B. 1943. The experimental production of pseudohermaphroditism in the monkey, in: Essays in Biology, University of California Press, Berkeley, pp. 583–607.
Vickers, T. H. 1967. The thalidomide embryopathy in hybrid rabbits. Br. J. Exp. Pathol. 48:107–117.
Vondruska, J. F., Fancher, O. E., and Calandra, J. C. 1971. An investigation into the teratogenic potential of captan, folpet, and difolatan in nonhuman primates. Toxicol. Apbl. Pharmacol. 18:619–624.
Walker, B. E. 1965. Cleft palate produced in mice by human-equivalent dosage with triamcinolone. Science 149:862–863.
Walker, B. E. 1967. Induction of cleft palate in rabbits by several glucocorticoids. Proc. Soc. Exp. Biol. Med. 125:1281–1284.
Walker, B. E. 1971. Induction of cleft palate in rats with antiinflammatory drugs. Teratology 4:39–42.
Weicker, H. 1965. 100 children with thalidomide embryopathy, presented at XIth International Congress of Pediatrics, Tokyo.
Wells, L. J., and van Wagenen, G. 1954. Androgen-induced female pseudohermaphroditism in the monkey (Macaca mulatta) : anatomy of the reproductive organs. Contrib. Embryol. Carnegie Inst. 35:93–106.
Whalen, R. E., Peck, C. K., and Lopiccolo, J. 1966. Virilization of female rats by prenatally administered progestins. Endocrinology 78:965–970.
Wharton, L. R., and Scott, R. B. 1964. Experimental production of genital lesions with norethindrone. Am. J. Obstet. Gynecol. 89:701–715.
Wilkins, L. 1960. Masculinization of female fetus due to use of orally given progestins. J. Am. Med. Assoc. 172:1028–1032.
Wilkins, L., Jones, H. W., Holman, G. H., and Stempfel, R. S. 1958. Masculinization of female fetus associated with administration of oral and intramuscular progestins during gestation: non-adrenal pseudohermaphroditism. J. Clin. Endocr. Met. 18:559–585.
Wilson, J. G. 1971. Use of rhesus monkeys in teratological studies. Fed. Proc. 30:104–109.
Wilson, J. G. 1972. Abnormalities of intrauterine development in nonhuman primates. Acta Endocrinol. 166(Suppl.):261–292.
Wilson, J. G. 1973. Environment and Birth Defects. Academic, New York.
Wilson, J. G. 1974. Teratologic causation in man and its evaluation in nonhuman primates, in: Birth Defects, A. G. Motulsky and W. Lenz, eds. Excerpta Medica, Amsterdam, pp. 191–203.
Wilson, J. G., and Fradkin, R. 1969. Comparison of teratogenic sensitivity of rats and rhesus monkeys. Teratology 2:272.
Wilson, J. G., and Gavan, J. A. 1967. Congenital malformations in nonhuman primates: Spontaneous and experimentally induced. Anat. Rec. 158:99–110.
Wilson, J. G., Scott, W. J., Ritter, E. J., and Fradkin, R. 1975. Comparative distribution and embryotoxicity of hydroxyurea in pregnant rats and rhesus monkeys. Teratology 11:169–178.
Wilson, J. G., Ritter, E. J., Scott, W. J., and Fradkin, R. 1977. Comparative distribution and embryotoxicity of acetylsalicylic acid in pregnant rats and rhesus monkeys. Toxicol. Appl. Pharmacol. 41:67–78.
Wilson, J. G., Scott, W. J., Ritter, E. J., and Fradkin, R. 1979. Comparative distribution and embryotoxicity of methotrexate in pregnant rats and rhesus monkeys. Teratology 19:71–80.
Woollam, D. H. M. 1962. Thalidomide and the mouse. Br. Med. J. 2:920.
Yamazaki, J. N. 1966. A review of the literature on the radiation dosage required to cause manifest central nervous system disturbances from in utero and postnatal exposure. Pediatrics 27:877–903.
Young, J. F., and Holson, J. F. 1978. Utility of pharmacokinetics in designing toxicological protocols and improving interspecies extrapolation. J. Environ. Pathol. Toxicol. 2:169–186.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hendrickx, A.G., Binkerd, P.E., Rowland, J.M. (1983). Developmental Toxicity and Nonhuman Primates. In: Kalter, H. (eds) Issues and Reviews in Teratology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-7311-1_6
Download citation
DOI: https://doi.org/10.1007/978-1-4615-7311-1_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-7313-5
Online ISBN: 978-1-4615-7311-1
eBook Packages: Springer Book Archive